There’s a saying in the markets that there’s always a bull market somewhere. Along similar lines, it’s almost always possible to find areas of growth in otherwise stagnant med-tech markets. While the overall performance of the orthopedic market has been pretty uninspiring of late, the extremities sub-sectors (upper and lower extremities) have been notable exceptions.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Spinal: Medtronic touts Euro win for 1st-of-its kind ReDux Plier
Mindray tag-teams CEO position | Personnel Moves
Mindray Medical (NYSE:MR) chief Li Xiting will share the corner office, so to speak, with new co-CEO Cheng Minghe, who takes the new title in addition to continuing as the company’s chief strategic officer.
Cheng is one of the founders of the Shenzhen, China-based company, and has worked in various roles since 1991.
RTI Biologics nabs Pioneer Surgical in $130M deal
RTI Biologics (NSDQ:RTIX) hopes a $130-million acquisition of Pioneer Surgical will help strengthen distribution and allow the company to expand into metal and synthetic implants. RTI today announced its intent to acquire Pioneer in a cash deal to acquire all of Pioneer’s outstanding stock.
Judge boosts royalties for NuVasive in patent loss to Medtronic
Histogenics appoints a new CEO | Personnel Moves
Histogenics has a new face in the corner office with the appointment of Peter Greenleaf, an AstraZeneca veteran favored by the board for his experience moving products toward commercialization.
The company has its eyes on an end-stage pivotal trial for NeoCart, a device that uses patients’ own cells to regenerate knee cartilage.
When conduct becomes a crime
By: John Roth
In my last post, I explained how FDA’s Office of Criminal Investigation (OCI) works when a small portion of the industry fails to adequately respond to regulatory action. For Abbott Laboratories and Amgen, the price for regulatory malfeasance was high: $1.4 billion – yes, billion – paid in criminal and civil penalties to the United States.
Pain management: St. Jude pays $40M for exclusive purchase option for Spinal Modulation
St. Jude Medical (NYSE:STJ) last week branded neurostimulation devices maker Spinal Modulation as its territory with a $40 million equity investment that gives St. Jude international distribution rights and an exclusive option to acquire the company down the road.
Symmetry Medical COO Chris Huntington steps down | Personnel Moves
Symmetry Medical (NYSE:SMA) said its chief operating officer Chris Huntington has left the company. Huntington founded Everest Metal Orthopedics and joined Symmetry amid a 2006 merger. He was promoted within Symmetry from his initial position as VP of business development.
InVivo tackles debt, aims for up-listing to a national exchange
Massachusetts-based spinal devices maker InVivo Therapeutics (OTC:NVIV) hopes to up-list to a national stock exchange now that it’s has paid down significant debts.
Boston Scientific can’t escape New Jersey whistleblower lawsuit
A New Jersey judge decided last week to allow accusers to move forward with a lawsuit against medical device giant Boston Scientific (NYSE:BSX) and its neuromodulation unit.